|
CYFIP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.374800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.380200E-01 |
| Normal-vs-Stage2 |
7.286600E-01 |
| Normal-vs-Stage3 |
9.126000E-01 |
| Normal-vs-Stage4 |
6.526200E-01 |
| Stage1-vs-Stage2 |
7.394200E-01 |
| Stage1-vs-Stage3 |
3.721600E-01 |
| Stage1-vs-Stage4 |
7.787000E-01 |
| Stage2-vs-Stage3 |
7.803400E-01 |
| Stage2-vs-Stage4 |
9.605600E-01 |
| Stage3-vs-Stage4 |
7.188800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.533800E-01 |
| Normal-vs-AfricanAmerican |
6.326200E-02 |
| Normal-vs-Asian |
2.085200E-01 |
| Caucasian-vs-AfricanAmerican |
1.499190E-01 |
| Caucasian-vs-Asian |
3.998200E-01 |
| AfricanAmerican-vs-Asian |
4.874400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.690000E-01 |
| Normal-vs-Female |
4.390600E-01 |
| Male-vs-Female |
9.296200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.343000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.862400E-01 |
| Normal-vs-Age(61-80Yrs) |
9.091800E-01 |
| Normal-vs-Age(81-100Yrs) |
8.867200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.182000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.766200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.279600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.826200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.721800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.465200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.222800E-01 |
| Classical-VS-Follicular |
1.416470E-04 |
| Classical-VS-Other |
1.054640E-01 |
| Classical-VS-Normal |
1.255640E-01 |
| Tall-VS-Follicular |
5.594400E-02 |
| Tall-VS-Other |
1.472010E-01 |
| Tall-VS-Normal |
3.536400E-01 |
| Follicular-VS-Other |
7.885600E-01 |
| Follicular-VS-Normal |
1.353240E-01 |
| Other-VS-Normal |
2.588000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.348000E-01 |
| Normal-vs-N1 |
6.131400E-01 |
| N0-vs-N1 |
5.277200E-01 |
|
|
